These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1523215)

  • 1. Cytoprotective action of beraprost sodium against peroxide-induced damage in vascular endothelial cells.
    Kainoh M; Nishio S; Nakadate T
    Pharmacology; 1992; 45(2):61-70. PubMed ID: 1523215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of beraprost sodium, a stable prostacyclin analogue, in development of monocrotaline-induced pulmonary hypertension.
    Miyata M; Ueno Y; Sekine H; Ito O; Sakuma F; Koike H; Nishio S; Nishimaki T; Kasukawa R
    J Cardiovasc Pharmacol; 1996 Jan; 27(1):20-6. PubMed ID: 8656653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of beraprost sodium on formation of lipid peroxides in ischemia and recirculation-induced cerebral injury.
    Kainoh M; Ueno S; Endoh T; Nakadate T
    Pharmacol Res; 1993; 28(3):249-58. PubMed ID: 8108315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General pharmacology of beraprost sodium. 2nd communication: effect on the autonomic, cardiovascular and gastrointestinal systems, and other effects.
    Murata T; Murai T; Kanai T; Ogaki Y; Sanai K; Kanda H; Sato S; Kajikawa N; Umetsu T; Matsuura H
    Arzneimittelforschung; 1989 Aug; 39(8):867-76. PubMed ID: 2510743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide inhibits peroxide-mediated endothelial toxicity.
    Degnim AC; Morrow SE; Ku J; Zar HA; Nakayama DK
    J Surg Res; 1998 Mar; 75(2):127-34. PubMed ID: 9655085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the prostaglandin I2 analogue, beraprost sodium, on vascular cell adhesion molecule-1 expression in human vascular endothelial cells and circulating vascular cell adhesion molecule-1 level in patients with type 2 diabetes mellitus.
    Goya K; Otsuki M; Xu X; Kasayama S
    Metabolism; 2003 Feb; 52(2):192-8. PubMed ID: 12601631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of PGI2 analogue on vascular endothelial function and platelet aggregation in patients with NIDDM.
    Nishimura M; Nozaki O; Nakano H; Tsuchida H; Yamada K
    J Diabetes Complications; 1995; 9(4):330-3. PubMed ID: 8573759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of OP-41483.alpha-CD, a stable prostacyclin analog, on cultured endothelial cell dysfunction caused by 15(S)-hydroperoxy-5,8,11,13-eicosatetraenoic acid (15-HPETE) in vitro.
    Matsumoto R; Naka M; Omawari N; Fujitani B; Aishita H
    Life Sci; 1993; 52(15):1257-64. PubMed ID: 8385251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostacyclin does not play any cytoprotective role in endothelial cell injury induced by 15-hydroperoxy-eicosatetraenoic acid, an arachidonate lipoxygenase product.
    Ochi H; Morita I; Murota S
    Prostaglandins Leukot Essent Fatty Acids; 1990 Nov; 41(3):157-61. PubMed ID: 2281119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of beraprost sodium (Procylin), a stable prostaglandin I2 analogue, on a dorsal skin flap model in rats.
    Alexandrou K; Hata Y; Matsuka K; Matsuda H
    Scand J Plast Reconstr Surg Hand Surg; 1996 Mar; 30(1):17-22. PubMed ID: 8711437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pycnogenol protects vascular endothelial cells from t-butyl hydroperoxide induced oxidant injury.
    Rong Y; Li L; Shah V; Lau BH
    Biotechnol Ther; 1994-1995; 5(3-4):117-26. PubMed ID: 8608322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a prostaglandin I2 analogue, beraprost sodium, on burn-induced gastric mucosal injury in rats.
    Battal MN; Hata Y; Matsuka K; Ito O; Matsuda H; Yoshida Y; Kawazoe T; Nagao M
    Burns; 1997 May; 23(3):232-7. PubMed ID: 9232284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition by beraprost sodium of thrombin-induced increase in endothelial macromolecular permeability.
    Imai-Sasaki R; Kainoh M; Ogawa Y; Ohmori E; Asai Y; Nakadate T
    Prostaglandins Leukot Essent Fatty Acids; 1995 Aug; 53(2):103-8. PubMed ID: 7480071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of beraprost sodium, a stable prostaglandin I2 analogue, on platelet aggregation in diabetes mellitus.
    Kato H; Takashima T; Kishikawa H; Emura S; Ohmori K
    Int J Clin Pharmacol Res; 1996; 16(4-5):99-102. PubMed ID: 9172007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta-Carotene attenuates peroxide-induced vasoconstriction in the human placenta.
    Cueto SM; Romney AD; Wang Y; Walsh SW
    J Soc Gynecol Investig; 1997; 4(2):64-71. PubMed ID: 9101463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General pharmacology of beraprost sodium. 1st communication: effect on the central nervous system.
    Murata T; Sakaya S; Hoshino T; Umetsu T; Hirano T; Nishio S
    Arzneimittelforschung; 1989 Aug; 39(8):860-6. PubMed ID: 2510742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of Beraprost sodium on the survival of subcutaneous transferred jejunum after vascular pedicle interruption in a rat model.
    Alexandrou K; Hata Y; Matsuka K; Ito O; Matsuda H; Furuichi H; Ishizu N
    J Reconstr Microsurg; 1996 Jan; 12(1):39-46. PubMed ID: 8618225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacological and clinical properties of beraprost sodium, orally active prostacyclin analogue].
    Nishio S; Kurumatani H
    Nihon Yakurigaku Zasshi; 2001 Feb; 117(2):123-30. PubMed ID: 11233303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of oral beraprost sodium, a prostaglandin I2 analogue, on endothelium dependent vasodilatation in the forearm of patients with coronary artery disease.
    Ohata S; Ishibashi Y; Shimada T; Takahashi N; Sugamori T; Sakane T; Hirano Y; Oyake N; Murakami Y; Higami T
    Clin Exp Pharmacol Physiol; 2006 Apr; 33(4):381-7. PubMed ID: 16620305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of in-stent restenosis with beraprost sodium: an experimental study of short- and intermediate-term effects in dogs.
    Seiji K; Tsuda M; Matsuhashi T; Takase K; Miyachi H; Yamada T; Ishibashi T; Higano S; Takahashi S
    Clin Exp Pharmacol Physiol; 2009 Dec; 36(12):1164-9. PubMed ID: 19473194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.